Roth Capital analyst Chris Lewis was out yesterday with some bullish comments on Exact Sciences (EXAS), defining the stock’s price target at $20, and recommending buying the shares …
In a research note issued yesterday, William Blair analyst Brian Weinstein reiterated an Outperform rating on Exact Sciences Corporation (EXAS) on the heels of …
In a research note released Wednesday, William Blair analyst Brian Weinstein reiterated coverage on Exact Sciences Corporation (EXAS) with a Buy rating, after he spent the day at Exact Sciences’ headquarters in …
